| Patent | Date |
|---|
Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions
Grant 11,446,303 - Garland , et al. September 20, 2 | 2022-09-20 |
Modulators of RAS GTPase
App 20220227740 - Ungashe; Solomon B. ; et al. | 2022-07-21 |
Pyrazolopyrimidine modulators of RAS GTPase
Grant 11,390,626 - Garland , et al. July 19, 2 | 2022-07-19 |
Uridine Phosphorylase Inhibitors to Treat or Prevent Pulmonary Disease
App 20220008422 - Garland; William A. ; et al. | 2022-01-13 |
Modulators of RAS GTPase
App 20210261532 - Lennek; Annie L. ; et al. | 2021-08-26 |
Methods and Compositions for Treating Mucositis
App 20210236530 - Garland; William A. ; et al. | 2021-08-05 |
Methods and Compositions for Reducing Radiation Induced Toxicity
App 20210228583 - Garland; William A. ; et al. | 2021-07-29 |
Methods and Compositions for Maximizing the Prevention and/or Reduction of Various Maladies and Drug Side-Effects Using Uridine
App 20210228584 - Garland; William A. ; et al. | 2021-07-29 |
Uridine Phosphorylase (UPase) Inhibitors for Treatment of Liver Conditions
App 20200397790 - Garland; William A. ; et al. | 2020-12-24 |
Non-Mammalian RAS Transgenic Animal Model
App 20200390074 - Karg; Travis ; et al. | 2020-12-17 |
Methotrexate adjuvants to reduce toxicity and methods for using the same
Grant RE48,253 - Garland , et al. October 13, 2 | 2020-10-13 |
Pyrazolopyrimidine Modulators of RAS GTPase
App 20200239479 - Garland; William A. ; et al. | 2020-07-30 |
Non-mammalian RAS transgenic animal model
Grant 10,660,318 - Karg , et al. | 2020-05-26 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same
Grant 9,468,613 - Garland , et al. October 18, 2 | 2016-10-18 |
Non-Mammalian RAS Transgenic Animal Model
App 20160249593 - Karg; Travis ; et al. | 2016-09-01 |
Methotrexate adjuvants to reduce toxicity and methods for using the same
Grant 9,382,287 - Garland , et al. July 5, 2 | 2016-07-05 |
Compositions And Methods For Binding Lysophosphatidic Acid
App 20160152735 - SABBADINI; Roger A. ; et al. | 2016-06-02 |
Methods and reagents for detecting bioactive lipids
Grant 9,274,129 - Sabbadini , et al. March 1, 2 | 2016-03-01 |
Immune-derived moieties reactive against lysophosphatidic acid
Grant 9,217,749 - Sabbadini , et al. December 22, 2 | 2015-12-22 |
Pharmaceutical compositions for binding sphingosine-1-phosphate
Grant 9,181,331 - Sabbadini , et al. November 10, 2 | 2015-11-10 |
Compositions and methods for binding lysophosphatidic acid
Grant 9,163,091 - Sabbadini , et al. October 20, 2 | 2015-10-20 |
Doxorubicin Adjuvants to Reduce Toxicity and Methods for Using the Same
App 20150258046 - Garland; William A. ; et al. | 2015-09-17 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same
Grant 9,061,038 - Garland , et al. June 23, 2 | 2015-06-23 |
Methotrexate Adjuvants to Reduce Toxicity and Methods for Using the Same
App 20150072945 - Garland; William A. ; et al. | 2015-03-12 |
Novel Bioactive Lipid Derivatives, And Methods Of Making And Using The Same
App 20150031055 - SABBADINI; Roger A. ; et al. | 2015-01-29 |
Methotrexate adjuvants to reduce toxicity and methods for using the same
Grant 8,853,227 - Garland , et al. October 7, 2 | 2014-10-07 |
Bioactive lipid derivatives, and methods of making and using same
Grant 8,796,429 - Sabbadini , et al. August 5, 2 | 2014-08-05 |
Humanized Antibody Compositions And Methods For Binding Lysophosphatidic Acid
App 20140199293 - SABBADINI; Roger A. ; et al. | 2014-07-17 |
Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions
Grant 8,614,103 - Sabbadini , et al. December 24, 2 | 2013-12-24 |
Humanized antibody compositions and methods for binding lysophosphatidic acid
Grant 8,604,172 - Sabbadini , et al. December 10, 2 | 2013-12-10 |
Compositions and methods for treating ocular diseases and conditions
Grant 8,444,970 - Sabbadini , et al. May 21, 2 | 2013-05-21 |
Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
Grant 8,361,465 - Sabbadini , et al. January 29, 2 | 2013-01-29 |
Doxorubicin Adjuvants to Reduce Toxicity and Methods for Using the Same
App 20120329744 - Garland; William A. ; et al. | 2012-12-27 |
Compositions and Methods for Binding Lysophosphatidic Acid
App 20120195901 - SABBADINI; Roger A. ; et al. | 2012-08-02 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same
Grant 8,227,517 - Garland , et al. July 24, 2 | 2012-07-24 |
Humanized antibodies and compositions for binding sphingosine-1-phosphate
Grant 8,222,373 - Sabbadini , et al. July 17, 2 | 2012-07-17 |
Compositions and methods for binding lysophosphatidic acid
Grant 8,158,124 - Sabbadini , et al. April 17, 2 | 2012-04-17 |
Chemical inhibitors of inhibitors of differentiation
Grant 8,138,356 - Chaudhary , et al. March 20, 2 | 2012-03-20 |
Methotrexate Adjuvants to Reduce Toxicity and Methods for Using the Same
App 20110319419 - Garland; William A. ; et al. | 2011-12-29 |
Humanized antibodies and compositions for binding sphingosine-1-phosphate
Grant 8,067,549 - Sabbadini , et al. November 29, 2 | 2011-11-29 |
Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate
Grant 8,025,877 - Sabbadini , et al. September 27, 2 | 2011-09-27 |
Compositions and methods for binding sphingosine-1-phosphate
Grant 8,026,342 - Sabbadini , et al. September 27, 2 | 2011-09-27 |
Methotrexate adjuvants to reduce toxicity and methods for using the same
Grant 7,998,967 - Garland , et al. August 16, 2 | 2011-08-16 |
Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate
Grant 7,956,173 - Sabbadini , et al. June 7, 2 | 2011-06-07 |
Humanized Antibody Compositions And Methods For Binding Lysophosphatidic Acid
App 20110076267 - SABBADINI; Roger A. ; et al. | 2011-03-31 |
Use Of Anti- Sphingosine-1-phosphate Antibodies In Combination With Chemotherapeutic Agents
App 20110020319 - SABBADINI; Roger A. ; et al. | 2011-01-27 |
Compositions and methods for binding sphingosine-1-phosphate
Grant 7,829,674 - Sabbadini , et al. November 9, 2 | 2010-11-09 |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
Grant 7,794,713 - Sabbadini , et al. September 14, 2 | 2010-09-14 |
Compositions And Methods For Treating Ocular Diseases And Conditions
App 20100226916 - Sabbadini; Roger A. ; et al. | 2010-09-09 |
Pharmaceutical Compositions For Binding Sphingosine-1-phosphate
App 20100098700 - SABBADINI; Roger A. ; et al. | 2010-04-22 |
Compositions And Methods For Binding Lysophosphatidic Acid
App 20100034814 - SABBADINI; Roger A. ; et al. | 2010-02-11 |
Compositions And Methods For Binding Sphingosine-1-phosphate
App 20100003242 - SABBADINI; Roger A. ; et al. | 2010-01-07 |
Doxorubicin Adjuvants To Reduce Toxicity And Methods For Using The Same
App 20090325893 - Garland; William A. ; et al. | 2009-12-31 |
Methotrexate Adjuvants To Reduce Toxicity And Methods For Using The Same
App 20090325969 - Garland; William A. ; et al. | 2009-12-31 |
Rabbit monoclonal antibodies against mouse/human Id3 proteins
Grant 7,629,131 - Chen , et al. December 8, 2 | 2009-12-08 |
Chemical Inhibitors of Inhibitors of Differentiation
App 20090226422 - CHAUDHARY; Jaideep ; et al. | 2009-09-10 |
Compositions And Methods For The Treatment And Prevention Of Fibrotic, Inflammatory And Neovascularization Conditions
App 20090220523 - Sabbadini; Roger A. ; et al. | 2009-09-03 |
Humanized Antibodies And Compositions For Binding Sphingosine-1-phosphate
App 20090148443 - SABBADINI; Roger A. ; et al. | 2009-06-11 |
Compositions and Methods for Binding Lysophosphatidic Acid
App 20090136483 - SABBADINI; Roger A. ; et al. | 2009-05-28 |
Nucleic Acids Coding For Humanized Antibodies For Binding Sphingosine-1-phosphate
App 20090137037 - SABBADINI; Roger A. ; et al. | 2009-05-28 |
Humanized Antibodies And Compositions For Binding Sphingosine-1-phosphate
App 20090130099 - WILLIAMS; David ; et al. | 2009-05-21 |
Methods Of Using Humanized Antibodies And Compositions For Binding Sphingosine-1-phosphate
App 20090130100 - SABBADINI; Roger A. ; et al. | 2009-05-21 |
Rabbit monoclonal antibody against Id1 protein
Grant 7,517,663 - Chen , et al. April 14, 2 | 2009-04-14 |
Compositions And Methods For Treating Ocular Diseases And Conditions
App 20090074789 - SABBADINI; Roger A. ; et al. | 2009-03-19 |
Compositions And Methods For Binding Sphingosine-1-phosphate
App 20090010922 - SABBADINI; Roger A. ; et al. | 2009-01-08 |
Compositions And Methods For The Treatment And Prevention Of Fibrotic, Inflammatory, And Neovascularization Conditions Of The Eye
App 20080213274 - Sabbadini; Roger A. ; et al. | 2008-09-04 |
Immune-Derived Moieties Reactive Against Lysophosphatidic Acid
App 20080145360 - SABBADINI; Roger A. ; et al. | 2008-06-19 |
Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same
App 20080138334 - SABBADINI; Roger A. ; et al. | 2008-06-12 |
Methods and Reagents for Detecting Bioactive Lipids
App 20080090303 - SABBADINI; Roger A. ; et al. | 2008-04-17 |
Novel Bioactive Lipid Derivatives, and Methods of Making and Using Same
App 20070281320 - SABBADINI; Roger A. ; et al. | 2007-12-06 |
Rabbit monoclonal antibodies against mouse/human Id3 proteins
App 20070178531 - Chen; Jung-Shou ; et al. | 2007-08-02 |
Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions
App 20070148168 - Sabbadini; Roger A. ; et al. | 2007-06-28 |
Rabbit monoclonal antibody against Id1 protein
App 20060286609 - Chen; Jung-Shou ; et al. | 2006-12-21 |
Benzamides for neurodegenerative disorder treatment
Grant 6,140,369 - Flitter , et al. October 31, 2 | 2000-10-31 |
Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
Grant 6,083,989 - Flitter , et al. July 4, 2 | 2000-07-04 |
| 